Precigen says well over 500 patients have started its treatment for a disease long managed by repeated surgeries
The uptake figure offers early commercial traction data for a gene therapy targeting recurrent respiratory papillomatosis.
Read at Stock Titan →Full coverage · 8 outlets
- Stock Titan · lead
- Yahoo FinanceWhat Precigen (PGEN) Said on Its Q3 Earnings Call
- PR NewswirePrecigen Reports Third Quarter 2026 Results Highlighted by Strong Sequential PAPZIMEOS Revenue Growth and Positive Cash Flow Ahead of Guidance
- BenzingaPrecigen Q3 2026 Earnings Call Transcript
- NBC NewsAfter new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses
- National Institutes of Health (NIH)Rare Diseases
- National Archives (.gov)The Precision Medicine Initiative
- YahooWhat Precigen (PGEN) Said on Its Q3 Earnings Call